36 results on '"Tay, Edgar"'
Search Results
2. SEVERE FUNCTIONAL TRICUSPID VALVE REGURGITATION: PREDICTORS OF MORTALITY AND HEART FAILURE ADMISSION.
3. Outcomes from MitraClip Therapy in Functional Compared to Degenerative Mitral Regurgitation: Multi-centre Experience from the MitraClip Asia-Pacific Registry (MARS).
4. COMPARISON OF PATIENTS WITH LOW–FLOW VERSUS NORMAL–FLOW SEVERE AORTIC STENOSIS WITH PRESERVED LEFT VENTRICULAR EJECTION FRACTION
5. THE PREVALENCE OF THE “LOW–FLOW” PHENOMENON IN PATIENTS WITH MILD, MODERATE AND SEVERE AORTIC STENOSIS
6. MORTALITY ON THE WAITING LIST FOR TRANSCATHETER AORTIC VALVE IMPLANTATION. A SINGLE CENTER EXPERIENCE FROM VANCOUVER, CANADA
7. LONG TERM DURABILITY OF EDWARDS BALLOON EXPANDABLE TRANSCATHETER AORTIC VALVE IMPLANTATION
8. Impact of Left Ventricular Ejection Fraction on Clinical Outcomes in Bicuspid Aortic Valve Disease.
9. ASSOCIATION OF LEFT VENTRICULAR DILATATION PATTERNS WITH MORTALITY IN PATIENTS WITH MODERATE AND MODERATE-SEVERE AORTIC REGURGITATION.
10. IMPACT OF DIFFERING STAGES OF CHRONIC KIDNEY DISEASE ON TRANSCATHETER AORTIC VALVE IMPLANTATION OUTCOME IN AN ASIAN POPULATION.
11. SAFETY AND EFFICACY OF THE COMBINATION SIROLIMUS-ELUTING ENDOTHELIAL PROGENITOR CELL CAPTURE STENT IN PATIENTS WITH ST-SEGMENT ELEVATION ACUTE MYOCARDIAL INFARCTION: ONE YEAR FOLLOW-UP.
12. Transcatheter Aortic Valve Replacement With Early- and New-Generation Devices in Bicuspid Aortic Valve Stenosis.
13. SEVERE ATRIAL FIBRILLATION-RELATED FUNCTIONAL TRICUSPID VALVE REGURGITATION: PREDICTORS FOR HEART FAILURE ADMISSIONS.
14. THE ETHNIC GAP IN CLINICAL OUTCOMES OF SIGNIFICANT AORTIC STENOSIS IN THE ASIAN POPULATION.
15. THE ASIAN PERSPECTIVE OF DIMENSIONLESS INDEX IN PATIENTS WITH LOW-GRADIENT SEVERE AORTIC STENOSIS WITH PRESERVED EJECTION FRACTION.
16. THE ETHNIC GAP IN CLINICAL OUTCOMES OF SIGNIFICANT AORTIC STENOSIS IN THE ASIAN POPULATION.
17. SEVERE ATRIAL FIBRILLATION-RELATED FUNCTIONAL TRICUSPID VALVE REGURGITATION: PREDICTORS FOR HEART FAILURE ADMISSIONS.
18. THE ASIAN PERSPECTIVE OF DIMENSIONLESS INDEX IN PATIENTS WITH LOW-GRADIENT SEVERE AORTIC STENOSIS WITH PRESERVED EJECTION FRACTION.
19. ETHNIC DIFFERENCES IN COMPUTED TOMOGRAPHY AORTIC VALVE CALCIUM QUANTIFICATION IN PATIENTS WITH AORTIC STENOSIS.
20. INADEQUATELY LOW LEFT VENTRICULAR MASS IN PATIENTS WITH AORTIC VALVE STENOSIS: IMPROVED LEFT VENTRICULAR CONTRACTILITY AND CLINICAL OUTCOMES?
21. TCT-638 Diabetes Mellitus Confers Worse Clinical Outcomes at 1 Year Compared to Non–Diabetes Mellitus in an All-Comer Population Implanted With Biodegradable Polymer Everolimus-Eluting Stents.
22. TCT-305 Real-World Experience of Biodegradable-Polymer Drug Eluting Stents Versus Second-Generation Durable-Polymer Drug-Eluting Stents in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.
23. DIFFERENCES IN CLINICAL OUTCOMES AND ECHOCARDIOGRAPHIC PROFILES OF PATIENTS WITH ATRIAL FIBRILLATION IN MEDICALLY-MANAGED SEVERE AORTIC STENOSIS AND PRESERVED LEFT VENTRICULAR EJECTION FRACTION.
24. AORTIC STENOSIS AND FUNCTIONAL MITRAL REGURGITATION: UNDERSTANDING THE RELATIONSHIP BETWEEN MORPHOLOGY AND FUNCTION ACCORDING TO LEFT VENTRICULAR CONCENTRICITY AND DILATATION.
25. COMPARING THE IMPACT OF CONCOMITANT SIGNIFICANT MITRAL REGURGITATION ON THE ECHOCARDIOGRAPHIC PROFILE OF PATIENTS WITH LOW-FLOW VERSUS NORMAL-FLOW SEVERE AORTIC STENOSIS AND PRESERVED LEFT VENTRICULAR EJECTION FRACTION.
26. TCTAP A-063 Medium-term Clinical Outcomes of the Everolimus-eluting Bioresorbable Vascular Scaffold in Real-world Practice.
27. TCTAP A-148 Drug Eluting Stents Versus Drug Eluting Balloons in the Treatment of Very Small De Novo Coronary Artery Disease.
28. INCIDENCE AND PREDICTORS OF TARGET LESION FAILURE IN A MULTI-ETHNIC ASIAN POPULATION RECEIVING THE SYNERGY CORONARY STENT: A PROSPECTIVE ALL-COMERS REGISTRY.
29. SAFETY AND EFFICACY OF SMALL VESSEL STENTING WITH 2 MM DRUG ELUTING STENTS IN REAL WORLD CLINICAL PRACTICE.
30. TCTAP A-052 Medium Term Target Lesion Failure in Patient Treated with Bioresorbable Vascular Scaffold.
31. TCT-104 Clinical Outcomes of Transcatheter Aortic Valve Replacement for Bicuspid Aortic Valve Stenosis.
32. TCT-92 Transcatheter Aortic Valve Replacement in Asian Pacific Countries.
33. TRANSCATHETER VALVE IN VALVE IMPLANTATION FOR FAILED BIOPROSTHETIC HEART VALVES
34. TRANSCATHETER AORTIC VALVE IMPLANTATION (TAVI) IN BICUSPID AORTIC STENOSIS
35. PAIEON'S C-THV SYSTEM - A NOVEL REAL-TIME IMAGE PROCESSOR TO FACILITATE TRANSCATHETER AORTIC VALVE IMPLANTATION (TAVI).
36. TRANSCATHETER AORTIC VALVE IMPLANTATION: SINGLE CENTRE OUTCOMES FROM THE FIRST 250 HIGH-RISK PATIENTS
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.